Grocers race to feed a shrinking appetite — and the shoppers who fill it faster than food companies can reformulate.

For three years the industry has treated GLP-1 drugs as a slow-moving story — something to watch, model, and hedge against. The numbers coming in now say otherwise.

https://phillempert.substack.com/p/the-glp-1-reckoning-what-the-numbers